• FDA Approves Avastin in Combination with Chemotherapy as Treatment for Advanced Ovarian Cancers
  • Phase 3 Trial Evaluating Add-on Tecentriq for Advanced Ovarian Cancer Is Recruiting Participants
  • American Cancer Society Reports Covers Gains in Treatment and Prevention, and Challenges That Remain
  • Phase 3 Trial Testing Pamiparib as Maintenance Therapy for Ovarian Cancer Recruiting Patients in China
  • Emotional Burden of Ovarian Cancer High But Often Overlooked, Review Aiming to ‘Amplify’ Patient Voice Reports
  • Votrient Maintenance Therapy Fails to Improve Survival in Advanced Ovarian Cancer Patients, Trial Results Show
  • European Commission Approves Clovis’ Rubraca for Recurrent Ovarian Cancer
  • Phase 3 Trial to Assess TTFields plus Taxol in Platinum-resistant Ovarian Cancer Patients
  • Mirvetuximab Soravtansine Combo Therapies Show Promise for Ovarian Cancer, Clinical Trial Shows
  • Phase 2 Trial Seeking Patients for Zejula-Avastin Combo as Maintenance Therapy for Advanced Ovarian Cancer
  • Update on Apealea, Potential Ovarian Cancer Therapy, Set for ASCO 2018 in June
  • Protein Levels Could Replace Genetic Tests for Detecting ARID1A Mutations